Cited by 351Amyotrophic Lateral Sclerosis ResearchHereditary Neurological DisordersAlzheimer's disease research and treatments

Understanding the role of TDP-43 and FUS/TLS in ALS and beyond

Open access
Da Cruz, Sandrine, Cleveland, Don W·2011·Current Opinion in Neurobiology

Abstract

Dominant mutations in two DNA/RNA binding proteins, TDP-43 and FUS/TLS, are causes of inherited Amyotrophic Lateral Sclerosis (ALS). TDP-43 and FUS/TLS have striking structural and functional similarities, implicating alterations in RNA processing as central in ALS. TDP-43 has binding sites within a third of all mouse and human mRNAs in brain and this binding influences the levels and splicing patterns of at least 20% of those mRNAs. Disease modeling in rodents of the first known cause of inherited ALS-mutation in the ubiquitously expressed superoxide dismutase (SOD1)-has yielded non-cell autonomous fatal motor neuron disease caused by one or more toxic properties acquired by the mutant proteins. In contrast, initial disease modeling for TDP-43 and FUS/TLS has produced highly varied phenotypes. It remains unsettled whether TDP-43 and FUS/TLS mutants provoke disease from a loss of function or gain of toxicity or both. TDP-43 or FUS/TLS misaccumulation seems central not just to ALS (where it is found in almost all instances of disease), but more broadly in neurodegenerative disease, including frontal temporal lobular dementia (FTLD-U) and many examples of Alzheimer's or Huntington's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.conb.2011.05.029

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysfunction of TDP43 and FUS leads to phenotypes characteristic of ALS and FTLD.

    “Dysfunction of transactivating response DNA binding protein (TDP43; also known as TARDBP) and fused in sarcoma (FUS; also known as TLS) lead to phenotypes that are characteristic of amyotrophic lateral sclerosis (ALS) and frontal temporal lobar disease (FTLD)”

    From The neurogenetics of alternative splicing (2016) · cites this paper as [155]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 77 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Da Cruz, S., & Cleveland, D. W.
Affiliations
University of California San Diego (US)
Corresponding author
Cleveland, Don W
Venue
Current Opinion in Neurobiology
Publisher
Elsevier BV
Published
2011-12
Volume
21
Issue
6
Pages
904-919
ISSN
0959-4388 (ISSN-L)
OpenAlex
W2135457495
Cited by
351
References
77
Citations by year
2026: 5 · 2025: 12 · 2024: 18 · 2023: 16 · 2022: 17 · 2021: 26 · 2020: 25 · 2019: 17 · 2018: 16 · 2017: 22 · 2016: 21 · 2015: 34 · 2014: 31 · 2013: 48 · 2012: 40
FWCI
4.80
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Wellcome Trust (089701)
  • National Institute of Neurological Disorders and Stroke (NS 27036, RC1NS069144, R37NS027036, R01NS027036)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
TDP-43, FUS/TLS, amyotrophic lateral sclerosis, RNA-binding proteins, RNA processing, mRNA splicing, SOD1, disease modeling, neurodegenerative diseases, Alzheimer's disease, Huntington's disease
MeSH terms
Amyotrophic Lateral Sclerosis, Animals, DNA-Binding Proteins, Humans, Mutation, RNA-Binding Protein FUS

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review